Your session is about to expire
← Back to Search
Dry needling for Delayed Onset Muscle Soreness (TDNDOMS Trial)
TDNDOMS Trial Summary
This trial found that dry needling is no more effective than sham for treating delayed onset muscle soreness.
- Delayed Onset Muscle Soreness
TDNDOMS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TDNDOMS Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is participation in this clinical trial open to me?
"Individuals who have muscle tissue and are in the age group of 18 to 35 years old may be eligible to join this trial. 36 participants will be needed for enrollment."
Are researchers presently recruiting individuals for the clinical trial?
"Affirmative, the data hosted on clinicaltrials.gov points to this research study being open for recruitment. The trial was first posted in March of 2019 and its most recent update happened in March 2022. In total 36 participants are needed from a single site."
Are youthful participants being allowed to join this experiment?
"The age range for this investigation is 18 to 35. Meanwhile, there are 5 trials specifically catering to those under the legal adult threshold and 16 clinical studies intended for seniors over 65 years old."
How many participants are included in this experiment?
"Affirmative. According to clinicaltrials.gov, the trial that commenced on March 30th 2019 is now actively recruiting patients - with a total of 36 needed from one location. This information was last updated on March 9th 2022."
Share this study with friends
Copy Link
Messenger